Τίτλος – Title
|
Η Ανασταλτική Δράση των μη Στεροειδών Αντιφλεγμονωδών Φαρμάκων στην Πώρωση των Καταγμάτων The Inhibitory Effect of Non-steroidal Anti-inflammatory Drugs in Fracture Healing |
|
Συγγραφέας – Author
|
Χαράλαμπος Δόκος και Μυρωνίδου-Τζουβελέκη Μαρία Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς Ch. Dokos and M. Mironidou-Tzouveleki Laboratory of Pharmacology, Medical School, Aristotle Univesity, Thessaloniki, Greece |
|
Παραπομπή – Citation
|
Χαράλαμπος,Δ., Μυρωνίδου-Τζουβελέκη,Μ., : Η Ανασταλτική Δράση των μη Στεροειδών Αντιφλεγμονωδών Φαρμάκων στην Πώρωση των Καταγμάτων, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 25: 38-39 (2007)
Dokos,Ch., Mironidou-Tzouveleki,Μ., : The Inhibitory Effect of Non-steroidal Anti-inflammatory Drugs in Fracture Healing, Epitheorese Klin. Farmakol. Farmakokinet. 25: 38-39 (2007)
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
2007 – 2007
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek |
|
Παραγγελία – Αγορά –
Order – Buy |
Ηλεκτρονική Μορφή: pdf (15 €) –
Digital Type: pdf (15 €) pharmakonpress[at]pharmakonpress[.]gr |
|
Λέξεις κλειδιά – Keywords
|
–
Non-steroidal anti-inflammatory drugs, fracture healing
|
|
Λοιποί Όροι – Other Terms
|
Άρθρο Article |
|
Περίληψη – Summary
|
–
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for their characteristic pharmacological properties: they are good analgesic, antipyretic and anti-inflammatory agents. NSAIDs are inhibitors of cyclo-oxygenase enzyme (COX-1, COX-2 isomorphs) that regulates the production of prostaglandins from arachidonic acid (phospholipid derivative). Fracture healing is a complex procedure that is induced by topical and non-topical factors regulated by signal transduction pathways. Classical NSAIDs like indomethacin, ketorolac, diclofenac reduce the production of new bone tissue in fractures. Experimental models indicate that there is poor mineralization of demineralized bone matrix grafts and Harvesian remodeling. New COX-2 selective inhibitors (coxibs) are still under research for their inhibitory effect in fracture healing. Seeking answers for the complex phenomenon of inhibition of bone healing, transgenic mice (null COX-1 and COX-2) are widely used so as to define the molecular and pharmacological basis. Although NSAIDs are prescribed for their analgesic and anti-inflammatory effects in fractures, it is best to avoid their use.
|
|
Αναφορές – References
|
1. Brunton L., Lazo J., Parker K.: Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Goodman and Gillman’s: The Pharmacological Basis οf Therapeutics. Chapter 27, McGraw-Hill, 2005
2. Katzung G.B. (ed.): Nonsteoidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics and drugs used in gout. Basic and Clinical Pharmacology. Chapter 36, Lange Medical Book, McGraw – Hill, 2004 3. Dandy J.D., Edwards J.D.: Essential Orthopaedics and Trauma. Churchill Livingstone, 2003 4. McRae R.: Pocketbook of Orthopaedics and Fractures. Churchill Livingstone, 2006 5. Seidenberg B.A, An H.Y.: Is there an inhibitory effect of COX-2 inhibitors on bone healing? Pharmacol. Res. 50: 151-156 (2004) 6. Nazon D., Abergel G., Hatem M.C.: Critical care in orthopedic and spine surgery. Crit. Care Clin. 19: 33-53 (2003) 7. Mullis H.B., Copland T.S., Weinhold S.P., Miclau T., Lester E.G., Bos D.G.: Effect of COX-2 inhibitors in non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury 37: 827-837 (2006) 8. Simon A.M., Manigrasso M.B., O’ Connor J.P.: Cyclo-oxygenase-2 function is essential for bone fracture healing. J. Bone Miner. Res. 17: 977-978 (2002) 9. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Roiser R.N., O’Keffe R.J.: Cyclooxygenase-2 regulates mesechymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109: 1405-1415 (2002) 10. Adohpson P., Abbaszadeghan H., Jonsson U., Dalen N., Sjoberg H.E., Kalen S.: No effects of pirozicam on osteopenia and recovery after Colles ‘s fracture. Arch. Orthop. Trauma Surg. 112: 127-130 (1993) |
Online ISSN 1011-6575
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
|
||
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek
|
|
Παραγγελία – Αγορά –
Order – Buy |
pharmakonpress[at]pharmakonpress[.]gr
|
|
pharmakonpress[at]pharmakonpress[.]gr
|